IP Library Granted Patent US 10,934,533
Granted Patent B1
US 10,934,533 · App. 16/598,554 · Granted Mar 2, 2021

Variant DNA polymerases having improved properties and method for improved isothermal amplification of a target DNA

Inventors: Jennifer Ong (Salem, MA); Nathan Tanner (West Newbury, MA); Yinhua Zhang (North Reading, MA); Yanxia Bei (Ipswich, MA); Vladimir Potapov (Auburndale, MA)
Assignee: New England Biolabs, Inc.
C12N9/1252C12N7/00C12Y207/07007
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,934,533
App. No.
16/598,554
Granted
Mar 2, 2021
Kind
B1
Abstract

Variants of the bacteriophage B103 DNA polymerase are described herein. The variant has improved properties, that include when compared to wild-type Phi29 DNA polymerase, at least one of the following: increased thermostability, improved reaction rate for DNA amplification, reduced background and a reduction of bias. Methods of using the DNA polymerase variant are also described herein.

Claims (27)

1. A DNA polymerase comprising an amino acid sequence that has at least 95% sequence identity with SEQ ID NO:2 and at least one amino acid substitution selected from the group consisting of: A147K, R221Y, A318G, A503M, I511V, R544K and T550K.

2. The DNA polymerase according to claim 1 , further comprising at least 2 amino acid substitutions selected from the group consisting of: A147K, R221Y, A318G, A503M, I511V, R544K and T550K.

3. The DNA polymerase according to claim 1 , further comprising at least 3 amino acid substitutions selected from the group consisting of: A147K, R221Y, A318G, A503M, I511V, R544K and T550K.

4. The DNA polymerase according to claim 1 , further comprising at least 4 amino acid substitutions selected from the group consisting of: A147K, R221Y, A318G, A503M, I511V, R544K and T550K.

5. The DNA polymerase according to claim 1 , further comprising at least 5 amino acid substitutions selected from the group consisting of: A147K, R221Y, A318G, A503M, I511V, R544K and T550K.

6. The DNA polymerase according to claim 1 , further comprising at least 6 amino acid substitutions selected from the group consisting of: A147K, R221Y, A318G, A503M, I511V, R544K and T550K.

7. The DNA polymerase according to claim 1 , further comprising 7 amino acid substitution that consist of A147K, R221Y, A318G, A503M, I511V, R544K and T550K.

8. The DNA polymerase according to claim 1 , further comprising substitutions at one or more positions selected from 339, 359, 383 and 384.

9. The DNA polymerase according to claim 1 , wherein the DNA polymerase is a fusion protein.

10. A DNA polymerase composition comprising at least 99% sequence identity with SEQ ID NO:5.

11. A kit comprising:

(i) the DNA polymerase according to claim 1 ; and

(ii) a reaction buffer.

12. The kit of claim 11 , wherein the DNA polymerase is lyophilized and/or the reaction buffer is in concentrated form.

13. The kit of claim 11 , further comprising one or more primers.

14. The kit of claim 13 , whereon the primers are selected from the group consisting of: random primers, exonuclease-resistant primers and primers having chemical modifications.

15. The kit of claim 1 , further comprising one or more dNTPs, crowding agents and/or cationic, anionic, zwitterionic or non-ionic detergents.

16. A method for improved isothermal amplification of a target DNA, comprising:

preparing a reaction mix comprising the target DNA with a DNA polymerase of claim 1 , dNTPs and, optionally, one or more primers; and amplifying the target DNA isothermally.

17. The method according to claim 16 , further comprising amplifying the target DNA at an amplification temperature in the range of 30° C.-42° C.

18. The method according to claim 16 , wherein the target DNA is linear or circular.

19. The method according to claim 16 , wherein the target DNA is a whole genome or a target DNA sequence therein.

20. The method according to claim 16 , further comprising amplifying the target DNA at a temperature in the range of 30° C.-42° C.; and obtaining a higher yield within 2 hours of amplified DNA compared to the yield obtained with wild-type Phi29 DNA polymerase under the same reaction conditions.

21. The method according to claim 16 , further comprising amplifying the target DNA at a temperature in the range of 30° C.-42° C. and obtaining a higher rate of amplification compared to the rate of amplification using wild-type Phi29 DNA polymerase under the same reaction conditions.

22. The method according to claim 16 , further comprising amplifying the target DNA at a temperature in the range of 30° C.-42° C. and obtaining a more even representation of the substrate DNA compared to the biased representation of wild-type Phi29 DNA polymerase under the same reaction conditions.

23. The method according to claim 16 , further comprising amplifying the target DNA at a temperature in the range of 30° C.-42° C., and obtaining reduced background compared to amplifying the substrate DNA with wild-type Phi29 DNA polymerase under the same reaction conditions.

24. The method according to claim 16 , further comprising amplifying the target DNA in a high salt buffer.

Assignments (2)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Sep 27, 2023
From: NEW ENGLAND BIOLABS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065044/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2019
From: ONG, JENNIFER; TANNER, NATHAN; ZHANG, YINHUA; BEI, YANXIA; POTAPOV, VLADIMIR
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 050790/0749 →